4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-24-001999
Chief Development Officer acquired 95,555 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jalota Deepika Chief Development Officer | 2024-01-18 | Grant or award | +95,555 | 125,501 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Jalota Deepika Chief Development Officer | 2024-01-18 | Grant or award · Employee Stock Option (right to buy) | +225,095 | 225,095 | D: show line 2 in the form |
Loading xslF345X05/doc4.xml…